Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

BACKGROUND: According to new diagnostic guidelines for Alzheimer’s disease (AD), biomarkers enable estimation of the individual likelihood of underlying AD pathophysiology and the associated risk of progression to AD dementia for patients with mild cognitive impairment (MCI). Nonetheless, how confli...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexopoulos, Panagiotis, Werle, Lukas, Roesler, Jennifer, Thierjung, Nathalie, Gleixner, Lena Sophie, Yakushev, Igor, Laskaris, Nikolaos, Wagenpfeil, Stefan, Gourzis, Philippos, Kurz, Alexander, Perneczky, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146856/
https://www.ncbi.nlm.nih.gov/pubmed/27931251
http://dx.doi.org/10.1186/s13195-016-0220-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146856/
https://www.ncbi.nlm.nih.gov/pubmed/27931251
http://dx.doi.org/10.1186/s13195-016-0220-z

Ejemplares similares